SCHEMBL9073026

SCHEMBL9073026

Cc1ccc(CF)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.46
ALDH1A1 P00352 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM1A O60341 1/20 0.41
KDM4E B2RXH2 1/20 0.39
CCR2 P41597 1/20 0.38
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
AGTR1 P30556 1/20 0.37
S1PR1 P21453 1/20 0.37
RAPGEF4 Q8WZA2 1/20 0.37
IDO1 P14902 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PNMT P11086 1/20 0.35
HPGD P15428 2/20 0.35
SIGMAR1 Q99720 1/20 0.35
HTR2A P28223 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2662792 0.82 S1PR1 (0.41) S1PR1RAPGEF4IDO1SMN1; SMN2PNMT
SCHEMBL12107538 0.81 CYP3A4 (0.54) CYP3A4ALDH1A1NPSR1KDM1AKDM4E
P-Xylene SCHEMBL28217877 0.81 CYP3A4 (0.38) CYP3A4ALDH1A1NPSR1KDM4EMAPT
SCHEMBL4026046 0.79 CYP3A4 (0.48) CYP3A4ALDH1A1NPSR1KDM1AKDM4E
SCHEMBL30031076 0.79 CYP3A4 (0.48) CYP3A4ALDH1A1NPSR1KDM1AKDM4E
SCHEMBL1755262 0.79 MAPT (0.49) CYP3A4ALDH1A1NPSR1KDM1AKDM4E
P-Xylene SCHEMBL28217852 0.78 IDO1 (0.38) CYP3A4ALDH1A1MAPTAGTR1S1PR1
SCHEMBL9788481 0.78 IDO1 (0.58) IDO1SMN1; SMN2PNMTSIGMAR1
SCHEMBL2622769 0.78 ALDH1A1 (0.40) CYP3A4ALDH1A1GAAMAPTNPC1
SCHEMBL11086985 0.77 IDO1 (0.64) CYP3A4ALDH1A1NPSR1KDM1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1632483-B1 HETEROCYCLIC SUBSTITUTED CARBONYL DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS AVENTIS PHARMA INC (US) 2008-10-29 EP disclosed
WO-2008098244-A1 NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR METABASIS THERAPEUTICS, INC. (US) 2008-08-14 WO disclosed
CN-1668601-A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors JANSSEN PHARMACEUTICA NV (BE) 2005-09-14 CN disclosed